// App-Quantinova.ai

POS03 : Outcome after percutaneous treatment of chronic total occlusions with bioresorbable scaffolds

Researchers

Presenter

  • Trobs M

Principal Investigators

  • Achenbach S

  • Rother J

  • Schlundt C

Medical Centers

  • University of Erlangen-Nuernberg, Erlangen, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Chronic total occlusion

  • Myocardial infarction

  • Congestive heart failure

  • Venous thrombosis

  • Diabetes

  • Dyspnea

  • Angina

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved